Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sharif Askari, Fatemeh Saheb ^a   Sulaiman, Syed Azhar Syed ^a   Sharif Askari, Narjes Saheb ^a   Hussain, Ali Al Sayed ^b  

^a SCHOOL OF PHYSICS   (Malaysia)

^b DUBAI HEALTH AUTHORITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALTEPLASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FONDAPARINUX; FUROSEMIDE; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PARACETAMOL; PROPRANOLOL; SULFONYLUREA; WARFARIN; ANTICOAGULANT AGENT;

ADULT; ADVERSE DRUG REACTION; ADVERSE DRUG REACTION RISK ASSESSMENT SCORE; AGE DISTRIBUTION; AGED; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CHI SQUARE TEST; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT TOOL; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DROWSINESS; END STAGE RENAL DISEASE; FAINTNESS; FEMALE; GASTROINTESTINAL DISEASE; GENDER; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREDICTIVE VALUE; RISK ASSESSMENT; SCORING SYSTEM; SKIN BRUISING; THROMBOCYTOPENIA; CHEMICALLY INDUCED; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK; STATISTICAL MODEL;

AGED; ANTICOAGULANTS; FEMALE; GLOMERULAR FILTRATION RATE; HEMORRHAGE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK; RISK ASSESSMENT;

EID: 84899693167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095991     Document Type: Article

References (40)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, et al. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329: 15-19. (Pubitemid 38869995)
2. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279: 1200-1205. (Pubitemid 28193431)
3. Wester K, Jonnson AK, Sigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65: 573-579. (Pubitemid 351365134)
4. Manley HJ, McClaran ML, Overbay DK, Wright MA, Reid GM, et al. (2003) Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 41: 386-393. (Pubitemid 36152458)
5. Verbeeck RK, Musuamba FT (2009) Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol 65: 757-773.
6. Wilke RA, Lin DW, Roden DM, Watkins PB, Flockhart D, et al. (2007) Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov 6: 904-916. (Pubitemid 350042398)
7. Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, et al. (2001) Risk factors for adverse drug events among nursing home residents. Arch Intern Med 161: 1629-1634. (Pubitemid 32681144)
8. Onder G, Landi F, Della Vedova C, Atkinson H, Pedone C, et al. (2002) GIFA Study. Moderate alcohol consumption and adverse drug reactions among older adults. Pharmacoepidemiology and Drug Saf 11: 385-392. (Pubitemid 35023469)
9. Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, et al. (2010) Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 170: 1142-1148.
10. Catananti C, Liperoti R, Settanni S, Lattanzio F, Bernabei R, et al. (2009) Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharmacol Ther 86: 307-310.
11. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, et al. (1999) Prevention Study Group. Patient risk factors for adverse drug events in hospitalized patients. Arch of Intern Med 159: 2553-2560.
12. Steel K, Gertman PM, Crescenzi C, Anderson J (2004) Iatrogenic illness on a general medical service at a university hospital. Qual Saf Health Care 13: 76-80.
13. Gurwitz JH, Rochon P (2002) Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 162:1670-1672.
14. Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, et al. (2005) Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA) Investigators. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 165:790-795. (Pubitemid 40569433)
15. Helldén A, Bergman U, von Euler M, Hentschke M, Odar-Cederlöf I, et al. (2009) Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department. Drugs Aging 26: 595-606.
16. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, et al. (1994) Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10: 405-411. (Pubitemid 24339205)
17. World Health Organization (2004) International Classification of Diseases, Tenth Revision (ICD-10). Geneva, Switzerland. World Health Organization.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130: 461-470. (Pubitemid 29135798)
19. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (Suppl 1):S1-S266.
20. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356: 1255-1259.
21. Rozich JD, Haraden CR, Resar RK (2003) Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care 12: 194-200. (Pubitemid 36723946)
22. Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW (2004) Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 13: 306-314. (Pubitemid 39070900)
23. British Medical Association, Royal Pharmaceutical Society of Great Britain (2012) British National Formulary. London: BMA, RPS, (No 64).
24. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, et al. (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245. (Pubitemid 12149145)
25. Steyerberg EW, Eijkemans MJC, Harrell FE, Habbema JDF (2001) Prognostic modeling with logistic regression analysis in search of a sensible strategy in small data sets. Med Decis Making 21: 45-56. (Pubitemid 32245030)
26. Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 165: 710-718. (Pubitemid 46348374)
27. Lemeshow S, Hosmer DW (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115: 92-106. (Pubitemid 12205725)
28. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, et al. (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21: 128-138.
29. Pencina MJ, D' Agostino RB, D' Agostino RB, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172. (Pubitemid 351193639)
30. Steyerberg EW (2009) Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer.
31. Efron B, Tibshirani R (1993) An Introduction to the Bootstrap. London: Chapman and Hall.
32. Steyerberg EW, Harrell FE Jr, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, et al. (2001) Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54: 774-781. (Pubitemid 32722180)
33. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, et al. (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284: 835-842. (Pubitemid 30643610)
34. Johnston PE, France DJ, Byrne DW, Murff HJ, Lee B, et al. (2006) Assessment of adverse drug events among patients in a tertiary care medical center. Am J Health Syst Pharm 63: 2218-2227. (Pubitemid 44851435)
35. Hohl CM, Dankoff J, Colacone A, Afilalo M (2001) Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 38: 666-671. (Pubitemid 33131567)
36. Corsonello A, Pedone C, Lattanzio F, Onder G, Incalzi R (2011) Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients. Drugs Aging 28: 379-390.
37. Corsonello A, Pedone C, Corica F, Mazzei B, Di Lorio A, et al. (2005) Concealed renal failure and adverse drug reactions in older patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci 60: 1147-1151. (Pubitemid 41384484)
38. Charytan D, Kuntz RE (2006) The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 70: 2021-2030. (Pubitemid 44863392)
39. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081.
40. Kent DM, Hayward RA (2007) Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification. JAMA 298: 1209-1212. (Pubitemid 47403108)